Chemotherapy Treatment of Elderly Patients (≥70 Years) with Non-Small Cell Lung Cancer: A Seven-Year Retrospective Study of Real-Life Clinical Practice at Karolinska University Hospital, Sweden
Lung Cancer International · 2015
DOI: 10.1155/2015/317868 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lung Cancer International, 2015. Verfasst von Hirsh Koyi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Gävle Hospital, 80187 Gävle, Sweden ; Karolinska Institutet, Stockholm, Sweden ; Centre for Research and Developm…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
An increasing proportion of cancer patients are aged >65 years and many are aged >70 years. Treatment of the elderly with lung cancer has, therefore, become an important issue; so we performed a retrospective study of our patients to demonstrate how elderly patients with NSCLC are treated in real-life, clinical practice. All patients aged ≥70 years with NSCLC at our department were reviewed retrospectively. In total, 1059 patients (50.8% of all NSCLC patients). Of these patients, 243 (22.9%) received chemotherapy, 164 (70.4%) of whom were treated with a platinum doublet using carboplatin. Second- and third-line chemotherapy were given to 31.4% and 13.9% of patients, respectively. Median overall survival was 289 and 320 days for male and female patients, respectively. Patients with performance status (PS) 0 experienced significantly better survival than patients with PS1 or PS 2: 410, 314, and 204 days, respectively. Age was of less importance, with patients aged 70–79 years versus those aged ≥80 years. Treatment of elderly NSCLC patients with chemotherapy is feasible if they have a good PS and appears to prolong survival. In this study, we found no significant differences in survival either between age groups or genders.
Autor:innen und Institutionen
- Department of Respiratory Medicine, Gävle Hospital, 80187 Gävle, Sweden ; Karolinska Institutet, Stockholm, Sweden ; Centre for Research and Development, Uppsala University, County Council of Gävleborg, Gävle, Sweden.
- Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Solna, Stockholm, Sweden.
- Centre for Research and Development, Uppsala University, County Council of Gävleborg, Gävle, Sweden.
Zitieren
APA
Koyi, H., Hillerdal, G., Andersson, O., Kölbeck, K. G., Liv, P., & Brandén, E. (2015). Chemotherapy Treatment of Elderly Patients (≥70 Years) with Non-Small Cell Lung Cancer: A Seven-Year Retrospective Study of Real-Life Clinical Practice at Karolinska University Hospital, Sweden. Lung Cancer International. https://doi.org/10.1155/2015/317868
Vancouver
Koyi H, Hillerdal G, Andersson O, Kölbeck KG, Liv P, Brandén E. Chemotherapy Treatment of Elderly Patients (≥70 Years) with Non-Small Cell Lung Cancer: A Seven-Year Retrospective Study of Real-Life Clinical Practice at Karolinska University Hospital, Sweden. Lung Cancer International. 2015. doi:10.1155/2015/317868
BibTeX
@article{Koyi2015,
author = {Koyi, Hirsh and Hillerdal, Gunnar and Andersson, Olov and Kölbeck, Karl-Gustav and Liv, Per and Brandén, Eva},
title = {Chemotherapy Treatment of Elderly Patients (≥70 Years) with Non-Small Cell Lung Cancer: A Seven-Year Retrospective Study of Real-Life Clinical Practice at Karolinska University Hospital, Sweden},
journal = {Lung Cancer International},
year = {2015},
doi = {10.1155/2015/317868}
}
EUVIMED